Circulating levels of cytokines and risk of urologic cancers: a two-sample Mendelian randomization study.

doi:10.1186/s12885-024-13016-9

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Circulating levels of cytokines and risk of urologic cancers: a two-sample Mendelian randomization study.

BMC cancer - 10 Oct 2024

Song Jinbo, Sun Xiaoke, Wang Ting, Li Chao, Yuan Leihong

Abstract excerpt

BACKGROUND: Chronic inflammation is associated with the etiology of various cancers. However, there is a lack of systematic research in urologic cancers. This study aims to use a two-sample Mendelian randomization (MR) approach to evaluate the role of circulating cytokines in the development of urologic cancers. METHODS: We obtained the summary-level data for bladder cancer (373,295 cases and 372,016 controls),...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cytokines
Share to Finland
Share to Genome-Wide Association Study
Share to Kidney Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mendelian Randomization Analysis

Share to Prostatic Neoplasms

Share to Urinary Bladder Neoplasms

Share to Urologic Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 39390542
DOI: 10.1186/s12885-024-13016-9
PMCID: PMC11465925

Provenance

PubMed metadata and Literature Corpus relationships.